CSL (CMXHF) Stock Forecast & Price Target

Compare

76 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CMXHF Analyst Ratings

Moderate Buy

8 Buy

4 Hold

0 Sell

Based on 12 analysts giving stock ratings to

CSL

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CMXHF Stock 12 Month Forecast

Average Price Target

$156.80

▲(30.81% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for CSL in the last 3 months. The average price target is $156.80 with a high forecast of $187.19 and a low forecast of $124.35. The average price target represents a 30.81% change from the last price of $119.87.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"114":"$114","151":"$151","188":"$188","132.5":"$132.5","169.5":"$169.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":187.19035,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$187.19</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":156.8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$156.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":124.3526,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$124.35</span>\n  </div></div>","useHTML":true}}],"tickPositions":[114,132.5,151,169.5,188],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,115.62,121.12541153846155,126.63082307692308,132.1362346153846,137.64164615384615,143.1470576923077,148.65246923076924,154.15788076923076,159.6632923076923,165.16870384615385,170.6741153846154,176.17952692307693,181.68493846153848,{"y":187.19035,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,115.62,118.78769230769231,121.95538461538462,125.12307692307692,128.29076923076923,131.45846153846153,134.62615384615384,137.79384615384618,140.96153846153848,144.1292307692308,147.2969230769231,150.4646153846154,153.6323076923077,{"y":156.8,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,115.62,116.29173846153847,116.96347692307693,117.63521538461539,118.30695384615385,118.97869230769231,119.65043076923077,120.32216923076923,120.99390769230769,121.66564615384615,122.33738461538461,123.00912307692307,123.68086153846153,{"y":124.3526,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":178.57,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163.92,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":170.76,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":151.25,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":150.02,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":165.08,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":160.28,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":149.25,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":176.46,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.21,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.08,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.49,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.62,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$187.19

Average Price Target$156.80

Lowest Price Target$124.35

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$155.44

Hold

29.67%

Upside

Reiterated

12/16/25

Ord Minnett Remains a Hold on CSL (CMXHF)

Christine Trinh

Macquarie

$182.03→$124.35

Hold

3.74%

Upside

Downgraded

12/14/25

Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and CSL (Other OTC: CMXHF)

David Bailey

Morgan Stanley

$169.33

Buy

41.26%

Upside

Reiterated

12/03/25

Morgan Stanley Sticks to Their Buy Rating for CSL (CMXHF)

Steven Wheen

Jarden

$189.93→$187.19

Buy

56.16%

Upside

Reiterated

11/22/25

Jarden Sticks to Its Buy Rating for CSL (CMXHF)

Laura Sutcliffe

Citi

$148.83

Buy

24.16%

Upside

Reiterated

11/16/25

Analysts Conflicted on These Healthcare Names: CSL (Other OTC: CMXHF) and Ramsay Health Care (Other OTC: RMSYF)

Craig Wong-Pan

RBC Capital

$125.01→$149.49

Hold

24.71%

Upside

Reiterated

11/06/25

RBC Capital Remains a Hold on CSL (CMXHF)

Marcus Curley

UBS

$181.9

Buy

51.75%

Upside

Reiterated

11/06/25

UBS Sticks to Its Buy Rating for CSL (CMXHF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$170.65→$155.44

Hold

29.67%

Upside

Reiterated

10/29/25

Ord Minnett Keeps Their Hold Rating on CSL (CMXHF)

Davinthra Thillainathan

Goldman Sachs

$205.71→$140.29

Buy

17.04%

Upside

Reiterated

10/29/25

Goldman Sachs Reaffirms Their Buy Rating on CSL (CMXHF)

Shane Storey

Canaccord Genuity

$152.13→$148.83

Buy

24.16%

Upside

Upgraded

10/28/25

CSL upgraded to Buy from Hold at CanaccordCSL upgraded to Buy from Hold at Canaccord

Derek Jellinek

Morgans

$194.35→$165.04

Buy

37.68%

Upside

Reiterated

10/28/25

CSL (CMXHF) Gets a Buy from Morgans

Thomas Wakim

Bell Potter

$152.13→$128.98

Hold

7.60%

Upside

Reiterated

10/28/25

CSL (CMXHF) Gets a Hold from Bell Potter

Andrew Paine

CLSA

$208.36→$181.9

Buy

51.75%

Upside

Reiterated

10/13/25

CLSA Keeps Their Buy Rating on CSL (CMXHF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$170.65

Hold

42.37%

Upside

Reiterated

09/29/25

CSL (CMXHF) Gets a Hold from Ord Minnett

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$170.65

Hold

42.37%

Upside

Reiterated

09/16/25

Ord Minnett Sticks to Its Hold Rating for CSL (CMXHF)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$155.44

Hold

29.67%

Upside

Reiterated

12/16/25

Ord Minnett Remains a Hold on CSL (CMXHF)

Christine Trinh

Macquarie

$182.03→$124.35

Hold

3.74%

Upside

Downgraded

12/14/25

Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and CSL (Other OTC: CMXHF)

David Bailey

Morgan Stanley

$169.33

Buy

41.26%

Upside

Reiterated

12/03/25

Morgan Stanley Sticks to Their Buy Rating for CSL (CMXHF)

Steven Wheen

Jarden

$189.93→$187.19

Buy

56.16%

Upside

Reiterated

11/22/25

Jarden Sticks to Its Buy Rating for CSL (CMXHF)

Laura Sutcliffe

Citi

$148.83

Buy

24.16%

Upside

Reiterated

11/16/25

Analysts Conflicted on These Healthcare Names: CSL (Other OTC: CMXHF) and Ramsay Health Care (Other OTC: RMSYF)

Craig Wong-Pan

RBC Capital

$125.01→$149.49

Hold

24.71%

Upside

Reiterated

11/06/25

RBC Capital Remains a Hold on CSL (CMXHF)

Marcus Curley

UBS

$181.9

Buy

51.75%

Upside

Reiterated

11/06/25

UBS Sticks to Its Buy Rating for CSL (CMXHF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$170.65→$155.44

Hold

29.67%

Upside

Reiterated

10/29/25

Ord Minnett Keeps Their Hold Rating on CSL (CMXHF)

Davinthra Thillainathan

Goldman Sachs

$205.71→$140.29

Buy

17.04%

Upside

Reiterated

10/29/25

Goldman Sachs Reaffirms Their Buy Rating on CSL (CMXHF)

Shane Storey

Canaccord Genuity

$152.13→$148.83

Buy

24.16%

Upside

Upgraded

10/28/25

CSL upgraded to Buy from Hold at CanaccordCSL upgraded to Buy from Hold at Canaccord

Derek Jellinek

Morgans

$194.35→$165.04

Buy

37.68%

Upside

Reiterated

10/28/25

CSL (CMXHF) Gets a Buy from Morgans

Thomas Wakim

Bell Potter

$152.13→$128.98

Hold

7.60%

Upside

Reiterated

10/28/25

CSL (CMXHF) Gets a Hold from Bell Potter

Andrew Paine

CLSA

$208.36→$181.9

Buy

51.75%

Upside

Reiterated

10/13/25

CLSA Keeps Their Buy Rating on CSL (CMXHF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$170.65

Hold

42.37%

Upside

Reiterated

09/29/25

CSL (CMXHF) Gets a Hold from Ord Minnett

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$170.65

Hold

42.37%

Upside

Reiterated

09/16/25

Ord Minnett Sticks to Its Hold Rating for CSL (CMXHF)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CSL

1 Month

xxx

Success Rate

8/17 ratings generated profit

Average Return

-0.76%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 47.06% of your transactions generating a profit, with an average return of -0.76% per trade.

3 Months

xxx

Success Rate

6/17 ratings generated profit

Average Return

-2.01%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 35.29% of your transactions generating a profit, with an average return of -2.01% per trade.

1 Year

Andrew PaineCLSA

Success Rate

8/23 ratings generated profit

Average Return

-3.40%

reiterated a buy rating 2 months ago

Copying Andrew Paine's trades and holding each position for 1 Year would result in 34.78% of your transactions generating a profit, with an average return of -3.40% per trade.

2 Years

xxx

Success Rate

5/23 ratings generated profit

Average Return

-11.47%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 21.74% of your transactions generating a profit, with an average return of -11.47% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CMXHF Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CMXHF has received 21 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. CMXHF average Analyst price target in the past 3 months is 156.80.

Each month's total comprises the sum of three months' worth of ratings.

CMXHF Financial Forecast

CMXHF Earnings Forecast

Next quarter’s earnings estimate for CMXHF is $4.08 with a range of $3.68 to $4.32. The previous quarter’s EPS was $2.35. CMXHF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year CMXHF has Performed in-line its overall industry.

CMXHF Sales Forecast

Next quarter’s sales forecast for CMXHF is $8.44B with a range of $8.22B to $8.72B. The previous quarter’s sales results were $7.29B. CMXHF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year CMXHF has Performed in-line its overall industry.

CMXHF Stock Forecast FAQ

What is CMXHF’s average 12-month price target, according to analysts?

Based on analyst ratings, CSL’s 12-month average price target is 156.80.

What is CMXHF’s upside potential, based on the analysts’ average price target?

CSL has 30.81% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CMXHF a Buy, Sell or Hold?

CSL has a consensus rating of Moderate Buy which is based on 8 buy ratings, 4 hold ratings and 0 sell ratings.

What is CSL’s price target?

The average price target for CSL is 156.80. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $187.19 ,the lowest forecast is $124.35. The average price target represents 30.81% Increase from the current price of $119.87.

What do analysts say about CSL?

CSL’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of CMXHF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

CSL (CMXHF) Stock Forecast & Price Target

CMXHF Analyst Ratings

CMXHF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering CSL

CMXHF Analyst Recommendation Trends

CMXHF Financial Forecast

CMXHF Earnings Forecast

CMXHF Sales Forecast

CMXHF Stock Forecast FAQ

Detailed List of Analyst Forecasts